Francesca Falcetta

598 total citations
20 papers, 468 citations indexed

About

Francesca Falcetta is a scholar working on Molecular Biology, Biomaterials and Surgery. According to data from OpenAlex, Francesca Falcetta has authored 20 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Biomaterials and 3 papers in Surgery. Recurrent topics in Francesca Falcetta's work include Metabolomics and Mass Spectrometry Studies (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Mass Spectrometry Techniques and Applications (3 papers). Francesca Falcetta is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Mass Spectrometry Techniques and Applications (3 papers). Francesca Falcetta collaborates with scholars based in Italy, Switzerland and Netherlands. Francesca Falcetta's co-authors include Paolo Ubezio, Maurizio D’Incalci, Monica Lupi, Laura Brunelli, Roberta Pastorelli, Giuseppina Della Vittoria Scarpati, Chiara Carlomagno, Alfonso De Stefano, Sergio Marchini and Sabino De Placido and has published in prestigious journals such as Analytical Chemistry, Cancer Research and Scientific Reports.

In The Last Decade

Francesca Falcetta

20 papers receiving 467 citations

Peers

Countries citing papers authored by Francesca Falcetta

Since Specialization

Citations

This map shows the geographic impact of Francesca Falcetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Falcetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Falcetta more than expected).

Fields of papers citing papers by Francesca Falcetta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Falcetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Falcetta. The network helps show where Francesca Falcetta may publish in the future.

Co-authorship network of co-authors of Francesca Falcetta

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Falcetta. A scholar is included among the top collaborators of Francesca Falcetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Falcetta. Francesca Falcetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	EASY-FIA: A Readably Usable Standalone Tool for High-Resolution Mass Spectrometry Metabolomics Data Pre-Processing 2022 ·Metabolites ·(unknown), (unknown), Manuela Ferrario, Francesca Falcetta, Roberta Pastorelli, Laura Brunelli	5
2	A methodological approach to correlate tumor heterogeneity with drug distribution profile in mass spectrometry imaging data 2020 ·GigaScience ·(unknown), Geert Postma, Pietro Franceschi, Lavinia Morosi, Silvia Giordano, Francesca Falcetta, Raffaella Giavazzi, Enrico Davoli, L.M.C. Buydens, Jeroen J. Jansen	5
3	Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts 2019 ·Therapeutic Advances in Medical Oncology ·Francesca Ricci, Laura Brunelli, Roberta Affatato, Rosaria Chilà, (unknown), Stefano Indraccolo, Francesca Falcetta, Maddalena Fratelli, Robert Fruscio, Roberta Pastorelli, Giovanna Damia	36
4	Past-in-the-Future. Peak detection improves targeted mass spectrometry imaging 2018 ·Analytica Chimica Acta ·Francesca Falcetta, Lavinia Morosi, Paolo Ubezio, Silvia Giordano, Alessandra Decio, Raffaella Giavazzi, Roberta Frapolli, (unknown), Pietro Franceschi, Maurizio D’Incalci, Enrico Davoli	7
5	Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach 2018 ·Journal of Experimental & Clinical Cancer Research ·Elisa Caiola, Francesca Falcetta, Silvia Giordano, Mirko Marabese, Marina Chiara Garassino, Massimo Broggini, Roberta Pastorelli, Laura Brunelli	27
6	Drug-Homogeneity Index in Mass-Spectrometry Imaging 2018 ·Analytical Chemistry ·(unknown), Geert Postma, Lavinia Morosi, Silvia Giordano, Raffaella Giavazzi, Maurizio D’Incalci, Francesca Falcetta, Enrico Davoli, (unknown), Pietro Franceschi	7
7	Tumor progression and metastatic dissemination in ovarian cancer after dose‐dense or conventional paclitaxel and cisplatin plus bevacizumab 2018 ·International Journal of Cancer ·Francesca Bizzaro, Francesca Falcetta, (unknown), Alessandra Decio, Lucia Minoli, Eugenio Erba, Fedro A. Peccatori, Eugenio Scanziani, Nicoletta Colombo, Massimo Zucchetti, Maria Rosa Bani, Paolo Ubezio, Raffaella Giavazzi	10
8	Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer 2017 ·Cancer Research ·Francesca Falcetta, Francesca Bizzaro, (unknown), Maria Rosa Bani, Raffaella Giavazzi, Paolo Ubezio	6
9	Characterization of a metabolomic profile associated with responsiveness to therapy in the acute phase of septic shock 2017 ·Scientific Reports ·Alice Cambiaghi, Bernardo Bollen Pinto, Laura Brunelli, Francesca Falcetta, Federico Aletti, Karim Bendjelid, Roberta Pastorelli, Manuela Ferrario	56
10	Application of 3D Mass Spectrometry Imaging to TKIs 2017 ·Clinical Pharmacology & Therapeutics ·Lavinia Morosi, Silvia Giordano, Francesca Falcetta, Roberta Frapolli, Simonetta Andrea Licandro, Cristina Matteo, Massimo Zucchetti, Paolo Ubezio, Eugenio Erba, Sonja Visentin, Maurizio D’Incalci, Enrico Davoli	14
11	Metabolomic state as early indicator of responsiveness to therapy in the acute phase of septic shock 2017 ·Journal of Critical Care ·Alice Cambiaghi, Bernardo Bollen Pinto, Laura Brunelli, Francesca Falcetta, Giuseppe Baselli, Karim Bendjelid, Roberta Pastorelli, Manuela Ferrario	1
12	Small interfering RNA delivery through positively charged polymer nanoparticles 2016 ·Nanotechnology ·(unknown), Raffaele Ferrari, Monica Lupi, (unknown), Francesca Falcetta, Paolo Ubezio, Maurizio D’Incalci, Massimo Morbidelli, Davide Moscatelli	10
13	Integrated experimental and simulation study of the response to sequential treatment with erlotinib and gemcitabine in pancreatic cancer 2016 ·Oncotarget ·Paolo Ubezio, Francesca Falcetta, Laura Carrassa, Monica Lupi	6
14	Hplc–MS/MS Method to Measure Trabectedin in Tumors: Preliminary PK Study in A Mesothelioma Xenograft Model 2015 ·Bioanalysis ·(unknown), (unknown), (unknown), Simonetta Andrea Licandro, Ezia Bello, Roberta Frapolli, Francesca Falcetta, Maurizio D’Incalci, Roberta Libener, Federica Grosso, Pablo Avilés, Massimo Zucchetti	7
15	A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma 2014 ·Nanotechnology ·Monica Lupi, Claudio Colombo, Roberta Frapolli, Raffaele Ferrari, Leopoldo Sitia, (unknown), Ezia Bello, Simonetta Andrea Licandro, Francesca Falcetta, Paolo Ubezio, Paolo Bigini, Mario Salmona, Maurizio D’Incalci, Massimo Morbidelli, Davide Moscatelli	20
16	Integrated multiplatform method forin vitroquantitative assessment of cellular uptake for fluorescent polymer nanoparticles 2014 ·Nanotechnology ·Raffaele Ferrari, Monica Lupi, Francesca Falcetta, Paolo Bigini, (unknown), Fabio Fiordaliso, Cinzia Bisighini, Mario Salmona, Maurizio D’Incalci, Massimo Morbidelli, Davide Moscatelli, Paolo Ubezio	19
17	Dynamic Rendering of the Heterogeneous Cell Response to Anticancer Treatments 2013 ·PLoS Computational Biology ·Francesca Falcetta, Monica Lupi, Valentina Colombo, Paolo Ubezio	11
18	Synthesis of surfactant free PCL–PEG brushed nanoparticles with tunable degradation kinetics 2013 ·International Journal of Pharmaceutics ·Raffaele Ferrari, Claudio Colombo, (unknown), Monica Lupi, Paolo Ubezio, Francesca Falcetta, Maurizio D’Incalci, Massimo Morbidelli, Davide Moscatelli	39
19	A Specific miRNA Signature Correlates With Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer 2011 ·International Journal of Radiation OncologyBiologyPhysics ·Giuseppina Della Vittoria Scarpati, Francesca Falcetta, Chiara Carlomagno, Paolo Ubezio, Sergio Marchini, Alfonso De Stefano, (unknown), Maurizio D’Incalci, Sabino De Placido, Stefano Pepe	140
20	Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells 2010 ·Cancer Chemotherapy and Pharmacology ·Valentina Colombo, Monica Lupi, Francesca Falcetta, (unknown), Maurizio D’Incalci, Paolo Ubezio	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact